Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Zecotek Photonics Inc ZMSPF

Zecotek Photonics Inc is in the business of research and development of photonics technologies. The company is focused on creating advanced materials and integrated optoelectronic devices for high-resolution medical imaging, optical precision surgery, and biopharmaceutical research. It operates in three divisions which include Imaging systems, Optronics systems, and 3D display systems with labs located in Canada, Korea, Russia, Singapore, and the U.S.A. The company develops products such as scintillation crystals, solid-state, photodetectors, positron emission tomography scanning components, lasers, and 3D display and 3D printing technologies. These products are used in sectors such as healthcare, scientific and industrial.


GREY:ZMSPF - Post by User

Bullboard Posts
Post by All-in-Oneon Apr 26, 2012 2:15pm
127 Views
Post# 19839995

lawsuit could be $200M or more

lawsuit could be $200M or more

In a recent interview with Streetwise Reports, AlphaNorth Asset Management’s Steven Palmer commented on Zecotek Photonics. The somewhat obscure specialty biotechs and pharmas seek to add value by giving new life to older technologies and molecules. As President and Chief Investment Officer of AlphaNorth, Steven embraces this strategy to generate exceptional returns while mitigating some of the risks inherent in drug development. In this exclusive interview with The Life Sciences Report https://www.thelifesciencesreport.com/, Palmer shares favorite life sciences names that could offer huge returns.We thought you'd be interested in reading Steve Palmer's comments on Zecotek Photonics. Scroll Down to see these comments.Steve Palmer's Comments:


"A company that I am excited about is Zecotek Photonics Inc. I like to invest in companies that have multiple paths to success. This is the situation with Zecotek. The company has several products, plus a lawsuit. Each of these things could have a significantly positive impact. Zecotek's current market value is only $35M. We think the value of the lawsuit could be $200M or more. The company also has a 3D-screen technology that doesn't require glasses, a laser division and patented technology for crystals used in PET scanners for the medical industry. Each of these, if successfully commercialized, could also be worth several hundred million dollars in value to the company." View Article : https://www.thelifesciencesreport.com/pub/na/13203

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse